We speculate that local immune stimulation due to viral infection (including potentially the infection of endothelial cells) could synergize with circulating aPL antibodies and thereby lead to a particularly severe thrombo-inflammatory insult to the lungs of patients with COVID-19. The gene discussed is FASLG; the disease is infection.